PT-141 Guide & Calculator

Last updated: March 2026

Bremelanotide • Melanocortin Receptor Agonist for Sexual Health

🧮 PT-141 Dose Calculator

What is PT-141?

PT-141 (Bremelanotide) is a synthetic peptide hormone originally developed from Melanotan II. Unlike its predecessor, PT-141 was specifically designed to target sexual dysfunction without the unwanted tanning effects. The peptide works as a melanocortin receptor agonist, specifically targeting the MC3R and MC4R receptors in the brain.

PT-141 represents a breakthrough in sexual health treatment because it acts centrally through the nervous system rather than affecting blood flow like traditional treatments. This makes it effective for both physiological and psychological aspects of sexual dysfunction.

FDA Approval: Vyleesi

In June 2019, the FDA approved Vyleesi (bremelanotide injection) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. This marked a significant milestone as only the second FDA-approved treatment for female sexual dysfunction.

Vyleesi Clinical Trials

The approval was based on two large Phase 3 trials (RECONNECT studies) involving over 1,200 women with HSDD. Participants showed statistically significant improvements in sexual desire and reduction in distress related to low sexual desire.

How PT-141 Works

PT-141 activates melanocortin receptors (primarily MC3R and MC4R) in the hypothalamic areas of the brain associated with sexual arousal. This central nervous system approach differs significantly from PDE5 inhibitors like Viagra, which work peripherally on blood vessels.

Melanocortin Pathway

The melanocortin system regulates various physiological functions including appetite, inflammation, and sexual behavior. PT-141's selectivity for certain melanocortin receptors allows it to enhance sexual function while minimizing effects on pigmentation and appetite that were problematic with earlier compounds.

Dosing Protocols

PT-141 dosing varies significantly between FDA-approved pharmaceutical use and research applications. The timing and frequency are critical factors for optimal results.

Protocol	Dose	Timing	Frequency	Maximum
FDA (Vyleesi)	1.75mg	45 min before	As needed	Once per 24h, 8x/month
Research (Low)	0.5-1.0mg	45-60 min before	As needed	2-3x per week max
Research (Standard)	1.0-1.5mg	45-60 min before	As needed	2-3x per week max
Research (High)	1.5-2.0mg	45-60 min before	As needed	2x per week max

Timing Considerations

• Onset: Effects typically begin 45 minutes to 2 hours post-injection
• Peak: Maximum effects usually occur 2-6 hours after administration
• Duration: Effects can last 6-72 hours (highly individual)
• Planning: Most users inject 1-2 hours before desired activity

How to Reconstitute PT-141

PT-141 typically comes as lyophilized powder in 10mg vials. Proper reconstitution is essential for maintaining peptide stability and achieving accurate dosing.

Reconstitution Steps

1. Remove cap and clean rubber stopper with alcohol
2. Draw bacteriostatic water into syringe
3. Insert needle at 45° angle into vial
4. Inject water slowly down the glass wall (not directly onto powder)
5. Swirl gently - do NOT shake
6. Let stand until completely dissolved (may take 5-10 minutes)

Administration Methods

PT-141 is designed for subcutaneous injection, typically in the abdomen or thigh. Proper injection technique ensures optimal absorption and minimizes side effects.

Injection Sites

Injection Technique

1. Clean injection site with alcohol
2. Pinch skin to create a fold
3. Insert needle at 90° angle (or 45° for thin individuals)
4. Inject slowly and steadily
5. Hold for 3-5 seconds before withdrawing
6. Apply gentle pressure with alcohol pad

Side Effects & Safety Profile

PT-141's side effect profile is well-documented from clinical trials. Nausea is the most common side effect, occurring in approximately 40% of users at therapeutic doses.

Side Effect	Frequency	Severity	Duration
Nausea	~40%	Mild to Moderate	2-8 hours
Flushing	~20%	Mild	1-4 hours
Headache	~15%	Mild	2-6 hours
Injection site reaction	~10%	Mild	24-48 hours

Managing Side Effects

Clinical Research & Studies

PT-141 has been extensively studied in clinical trials, primarily focusing on female sexual dysfunction, though research in males has also shown promise.

Major Clinical Trials

Male Studies

While not FDA-approved for male use, several studies have investigated PT-141's effects in men with erectile dysfunction, showing promising results particularly in men with psychogenic ED.

PT-141 vs Other Treatments

Understanding how PT-141 compares to other sexual health treatments helps inform treatment decisions.

Treatment	Mechanism	Onset	For Women	For Men
PT-141	CNS (brain)	45-120 min	FDA approved	Off-label
Viagra/Cialis	Vascular (blood flow)	30-60 min	Limited efficacy	FDA approved
Flibanserin	Neurotransmitter	Daily dosing	FDA approved	Not indicated
Testosterone	Hormonal	Days to weeks	Off-label	FDA approved

Unique Advantages

• Central Action: Works on desire/arousal, not just physical function
• As-needed dosing: No daily medication requirement
• Broad effectiveness: Works for both psychological and physical causes
• Gender application: Effective in both men and women

Storage Guidelines

Proper storage is crucial for maintaining PT-141's potency and safety throughout its shelf life.

Form	Temperature	Duration	Notes
Lyophilized powder	2-8°C (refrigerated)	2+ years	Keep in original packaging
Lyophilized powder	Room temperature	6+ months	Keep dry and dark
Reconstituted	2-8°C (refrigerated)	4-6 weeks	Use bacteriostatic water
Reconstituted	Frozen (-20°C)	6+ months	Single-use aliquots recommended

Frequently Asked Questions

How long does PT-141 take to work?

PT-141 typically begins working 45 minutes to 2 hours after injection, with peak effects occurring 2-6 hours post-administration. The duration is highly variable, ranging from 6-72 hours depending on the individual.

Can PT-141 be used daily?

No, PT-141 should not be used daily. The FDA recommends maximum once per 24 hours and no more than 8 doses per month for Vyleesi. Research protocols typically suggest 2-3 times per week maximum to avoid tolerance and minimize side effects.

Does PT-141 work for men?

Yes, clinical studies show PT-141 is effective for men, particularly those with psychogenic erectile dysfunction or those who don't respond well to PDE5 inhibitors. However, it's not FDA-approved for male use.

What's the difference between PT-141 and Melanotan II?

PT-141 was developed from Melanotan II but with modifications to reduce tanning effects and focus on sexual function. PT-141 has much less effect on pigmentation while maintaining sexual enhancement properties.

Can I reduce nausea from PT-141?

Yes, nausea can often be managed by starting with lower doses, taking anti-nausea medication beforehand, avoiding empty stomach injection, and staying well-hydrated. Some users find taking it at bedtime helps sleep through the nausea period.

Is PT-141 legal?

PT-141 as a research peptide exists in a legal grey area - available for research purposes but not approved for human consumption. Vyleesi (pharmaceutical PT-141) is FDA-approved and available by prescription for women with HSDD.

How much does PT-141 cost?

Research PT-141 typically costs $50-150 per 10mg vial depending on source and quality. Vyleesi (prescription) costs approximately $400+ per month without insurance coverage.